Ankur Drugs

Ankur Drugs & Pharma has reported a standalone sales turnover of Rs 36.12 crore and a net loss of Rs 40.84 crore for the quarter ended Dec '12

Ankur Drugs Sep '12 sales at Rs 35.51 crore

Ankur Drugs & Pharma has reported a sales turnover of Rs 35.51 crore and a net loss of Rs 23.47 crore for the quarter ended Sep '12

Stocks in news: RIL, SML Isuzu, MRPL, Escorts

Stocks in news: RIL | SML Isuzu | MRPL | Escorts | Essar Shipping | Ind-Swift Labs | Syndicate Bank | Power Grid | SCI | Bank of Maharashtra | PNB | Hindalco and Ankur Drugs are stocks which are in news today.

Stocks in news: HDFC, SBI, Aventis Pharma, Tata Steel

HDFC | SBI | RIL | ABB | Aventis Pharma | Gujarat Gas | Tata Communications | Tata Steel | Mangalore Chemicals | Ankur Drug | Orbit Corp | Vijaya Bank | Shasun Pharma and Bank of Baroda are stocks, which are in the news today.

Defaulting cos will lose out on Yuan loans: Fitch Ratings

Chinese Yuan loans will not be available to the companies who are already defaulting by their previous local borrowing says Deep Mukherjee, Director, Fitch Ratings.

Will get approvals to restructure debt soon: Ankur Drugs

In an interview with CNBC-TV18, Purnandu Jain, CMD, Ankur Drugs outlined the contours of the company's corporate debt restructuring plan.

Ankur Drugs Dec '10 sales at Rs 150.19 crore

Ankur Drugs & Pharma has reported a sales turnover of Rs 150.19 crore and a net loss of Rs 20.09 crore for the quarter ended Dec '10